Loading... Please wait...
Fem-dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1 and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 20 years of research supports the oral use of GR-1 and RC-14 to colonize and protect the vaginal tract.
Clinical trials have shown that GR-1 and RC-14:
Fem-dophilus is manufactured under pharmaceutical GMP conditions with guaranteed potency and consistency. The probiotic strains in fem-dophilus are in a proprietary polysaccharide matrix, which protects the bacteria from stomach acid and enhances probiotic bacteria survival to the lower intestine.
Directions
For maintenance, take 1 capsule orally per day and increase to 2 capsules per day as needed, or take as directed by your qualified health care consultant.
Ingredients
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving % Daily Value
Total Probiotic Bacteria Lactobacillus rhamnosus GR-1 Lactobacillus reuteri RC-14 5 Billion cfu *
* Daily Value not established.
Other Ingredients: Dextrose anhydrate, potato starch, microcrystalline cellulose and magnesium stearate (vegetable source). Capsule consists of gelatin and titanium dioxide.
Contains: Dairy (casein, in trace amounts).
No wheat, no gluten, no soybeans, no egg, no fish/shellfish, no preservatives, no peanuts/tree nuts.
Note: We do not imply any medical claims from product reviews posted on this web site. >> Disclaimer